Literature DB >> 21391163

Abnormal glucose tolerance: a predictor of 30-day mortality in patients with decompensated liver cirrhosis.

S Hagel1, T Bruns, A Herrmann, A Stallmach, C Schmidt.   

Abstract

BACKGROUND: In liver cirrhosis an abnormal glucose tolerance correlates with a poor long-term prognosis. The aim of this study was to evaluate whether a disturbed glucose metabolism predicts the short-term prognosis in hospitalized patients with decompensated liver cirrhosis.
METHODS: Seventy-eight patients with liver cirrhosis were prospectively enrolled. Disturbed glucose metabolism was determined by a 75-g oral glucose tolerance test (OGTT) according to WHO criteria. Differences in survival were assessed by χ (2) test for 30-day mortality and by multivariate Cox proportional hazards analysis for long-term survival.
RESULTS: Impaired glucose tolerance (IGT) was diagnosed in 29 patients (37 %) and diabetes mellitus (DM) in 26 patients (33 %). A pathological OGTT result was a significant negative predictor of a poor 30-day survival compared to NGT (OR 8.6; p=0.03). DM but not IGT was an independent negative predictor of long-term survival (HR=1.89; p=0.04).
CONCLUSION: Disturbed glucose metabolism in hospitalized patients with decompensated liver cirrhosis is correlated with increased 30-day mortality. OGTT appears to be useful for identifying cirrhotic patients with poor short term prognosis. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21391163     DOI: 10.1055/s-0029-1245933

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  5 in total

Review 1.  Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

2.  A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.

Authors:  Taichiro Nishikawa; Nadège Bellance; Aaron Damm; Han Bing; Zhen Zhu; Kan Handa; Mladen I Yovchev; Vasudha Sehgal; Tyler J Moss; Michael Oertel; Prahlad T Ram; Iraklis I Pipinos; Alejandro Soto-Gutierrez; Ira J Fox; Deepak Nagrath
Journal:  J Hepatol       Date:  2014-02-26       Impact factor: 25.083

3.  Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis.

Authors:  Diego García-Compeán; Joel Omar Jáquez-Quintana; Fernando Javier Lavalle-González; José Alberto González-González; Linda Elsa Muñoz-Espinosa; Jesús Zacarías Villarreal-Pérez; Héctor J Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

4.  Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis.

Authors:  Lei Li; Yanhui Si; Mingrong Cheng; Lin Lang; Aijun Li; Baochi Liu
Journal:  Exp Ther Med       Date:  2022-08-22       Impact factor: 2.751

5.  Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study.

Authors:  Sudul Mananjala Senanayake; Madunil Anuk Niriella; Sanjaya Kumara Weerasinghe; Anuradhani Kasturiratne; Jerome Praneeth de Alwis; Arjuna Priyadarsin de Silva; Anuradha Supun Dassanayake; Hithanadura Janaka de Silva
Journal:  BMC Res Notes       Date:  2012-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.